Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hydralazine 25mg tablets
0205010J0AAAGAG
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 35,095 |
|
Hydralazine 50mg tablets
0205010J0AAAHAH
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 22,157 |
|
Apresoline 25mg tablets
0205010J0BBAAAG
|
Apresoline | Hydralazine hydrochloride | Cardiovascular System | 390 |
|
Hydralazine 10mg/5ml oral suspension
0205010J0AABTBT
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 22 |
|
Hydralazine 10mg tablets
0205010J0AABKBK
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 13 |
|
Hydralazine 25mg/5ml oral liquid
0205010J0AAA8A8
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 4 |
|
Hydralazine 5mg/5ml oral liquid
0205010J0AAA5A5
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 3 |
|
Apo-Hydralazine 10mg tablets
0205010J0BCAABK
|
Apo-Hydralazine | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Apresoline 20mg powder for solution for injection ampoules
0205010J0BBACAK
|
Apresoline | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 1.25mg/5ml oral liquid
0205010J0AABPBP
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 100mg/5ml oral liquid
0205010J0AABEBE
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 10mg/5ml oral solution
0205010J0AAA3A3
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 12.5mg/5ml oral liquid
0205010J0AABBBB
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 15mg/5ml oral liquid
0205010J0AABLBL
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 1mg/5ml oral liquid
0205010J0AABRBR
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 2.5mg/5ml oral liquid
0205010J0AABQBQ
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 20mg powder for solution for injection ampoules
0205010J0AAAKAK
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 20mg/5ml oral liquid
0205010J0AAA9A9
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 2mg/5ml oral liquid
0205010J0AABIBI
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 35mg/5ml oral suspension
0205010J0AABSBS
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 3mg/5ml oral liquid
0205010J0AABHBH
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 4mg/5ml oral liquid
0205010J0AABFBF
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 50mg/5ml oral liquid
0205010J0AAA4A4
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 62.5mg/5ml oral liquid
0205010J0AABABA
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Hydralazine 7.5mg/5ml oral liquid
0205010J0AAA7A7
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.